Journal
CELL
Volume 185, Issue 13, Pages 2210-2212Publisher
CELL PRESS
DOI: 10.1016/j.cell.2022.05.023
Keywords
-
Categories
Funding
- National Institutes of General Medical Sciences MIRA Program [R35 GM122561]
- Stony Brook University Office of the Vice President for Research Seed Grant
- Laufer Center for Physical and Quantitative Biology
Ask authors/readers for more resources
The researchers propose a new type of antiviral drugs that efficiently cure infected cells and minimize the chance of resistance.
Many approved drugs, including antivirals, are small-molecule inhibitors of disease-causing proteins. Such inhibitors often elicit resistance during treatment. Chaturvedi et al. propose new, feedback-disruptor (FD) antivirals that efficiently cure infected cells from viruses and minimize the chance of resistance, providing a new paradigm to treat viral infections and possibly other diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available